These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 25592196)

  • 1. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
    Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride/HDL cholesterol ratio and lipoprotein insulin resistance Score: Associations with subclinical atherosclerosis and incident cardiovascular disease.
    Flores-Guerrero JL; Been RA; Shalaurova I; Connelly MA; van Dijk PR; Dullaart RPF
    Clin Chim Acta; 2024 Jan; 553():117737. PubMed ID: 38142802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance.
    Shalaurova I; Connelly MA; Garvey WT; Otvos JD
    Metab Syndr Relat Disord; 2014 Oct; 12(8):422-9. PubMed ID: 24959989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents.
    Magge SN; Stettler N; Koren D; Levitt Katz LE; Gallagher PR; Mohler ER; Rader DJ
    J Clin Endocrinol Metab; 2011 May; 96(5):1549-54. PubMed ID: 21367935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin level and lipoprotein particle size.
    Hämäläinen P; Saltevo J; Kautiainen H; Mäntyselkä P; Vanhala M
    Lipids Health Dis; 2018 Jan; 17(1):10. PubMed ID: 29321013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
    Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
    Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
    Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
    Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study.
    Sokooti S; Flores-Guerrero JL; Heerspink HJL; Connelly MA; Bakker SJL; Dullaart RPF
    Cardiovasc Diabetol; 2021 Jul; 20(1):156. PubMed ID: 34321006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
    Howard BV
    Diabetes Care; 1993 Jan; 16(1):284-91. PubMed ID: 8422793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA).
    Kreis AJ; Wong TY; Islam FM; Klein R; Klein BE; Cotch MF; Jenkins AJ; Shea S; Wang JJ
    Diab Vasc Dis Res; 2009 Jan; 6(1):40-2. PubMed ID: 19156628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
    Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.